INPP5E Antibody

Shipped with Ice Packs
In Stock

Description

Target Overview: INPP5E

INPP5E (Inositol Polyphosphate-5-Phosphatase E) is a 72 kDa enzyme that hydrolyzes phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P3) and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) . Key roles include:

  • Regulating phosphoinositide signaling at primary cilia .

  • Modulating immune synapse formation in T-cells .

  • Maintaining chromosomal stability during mitosis .

Mutations in INPP5E are linked to Joubert syndrome and MORM syndrome, characterized by neurological, renal, and developmental abnormalities .

Applications of INPP5E Antibody

The INPP5E antibody is widely used in:

ApplicationResearch ContextKey Findings
Western BlotValidating INPP5E knockdown/knockout modelsSilencing INPP5E reduces protein levels (~70 kDa band depletion) .
ImmunofluorescenceLocalizing INPP5E in cilia and immune synapsesPolarized enrichment at T-cell immune synapses and centrioles .
Functional StudiesAssessing phosphoinositide dynamics in phagocytosis and viral infectionINPP5E loss increases PI(4,5)P2 at synapses, impairing T-cell activation .
Clinical ResearchDiagnosing ciliopathies and studying INPP5E mutationsDysfunctional INPP5E correlates with renal cysts and brain malformations .

3.1. Immune Synapse Regulation

  • INPP5E antibody staining revealed its concentration at immune synapses in Jurkat T-cells, where it interacts with CD3ζ, ZAP-70, and Lck to sustain T-cell receptor (TCR) signaling .

  • Silencing INPP5E disrupts CD3ζ polarization, reduces interleukin-2 secretion, and impairs PI(4,5)P2 clearance .

3.2. Viral Infection Mechanisms

  • INPP5E knockdown (validated via antibody-based assays) enhances herpes simplex virus infection by altering actin remodeling and viral attachment .

3.3. Mitotic Regulation

  • INPP5E antibody localization studies show its presence at centrosomes, kinetochores, and spindle midzones during mitosis, where it prevents aneuploidy .

Clinical Relevance

  • Joubert Syndrome: INPP5E antibodies help identify loss-of-function mutations in patient-derived cells .

  • Cancer Research: INPP5E is upregulated in cervical cancer and lymphomas but downregulated in gastric carcinomas, highlighting its dual role in tumorigenesis .

Technical Considerations

  • Validation: Ensure specificity using knockout controls (e.g., INPP5E-null cell lines) .

  • Cross-Reactivity: Verify reactivity across species (human, mouse, rat) .

  • Storage: Stable at -20°C in aliquots to prevent freeze-thaw degradation.

Challenges and Future Directions

  • Specificity Issues: Commercial antibodies may exhibit off-target binding to homologous phosphatases.

  • Therapeutic Potential: INPP5E-targeting antibodies could improve chimeric antigen receptor (CAR) T-cell therapy by modulating TCR signaling .

Product Specs

Buffer
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. Store at -20°C. Avoid freeze/thaw cycles.
Lead Time
We typically dispatch products within 1-3 working days after receiving your orders. Delivery times may vary depending on the purchasing method or location. Please consult your local distributor for specific delivery time estimates.
Synonyms
5-bisphosphate 5-phosphatase antibody; 72 kDa inositol polyphosphate 5-phosphatase antibody; Inositol polyphosphate 5 phosphatase antibody; INP5E_HUMAN antibody; Inpp5e antibody; Phosphatidylinositol (4,5) bisphosphate 5 phosphatase antibody; Phosphatidylinositol 4 antibody; Phosphatidylinositol polyphosphate 5 phosphatase type IV antibody; Phosphatidylinositol polyphosphate 5-phosphatase type IV antibody; PPI5PIV antibody
Target Names
Uniprot No.

Target Background

Function
INPP5E is a phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3), phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), and phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). It exhibits specificity for lipid substrates and is inactive towards water-soluble inositol phosphates. INPP5E plays a crucial role in the primary cilium by regulating ciliary growth and phosphoinositide 3-kinase (PI3K) signaling and stability.
Gene References Into Functions
  • miR598 promotes cell proliferation and cell cycle progression in colorectal carcinoma by targeting INPP5E. PMID: 29257251
  • INPP5E interacts with the N-terminus of RPGR, and its trafficking to cilia depends on the ciliary localization of RPGR. PMID: 28172980
  • INPP5E functions as an essential inhibitor of the PI3K/Akt/mTORC1 signaling axis in renal epithelial cells. It plays a critical role in suppressing Polycystic kidney disease (PKD) through its regulation of mTORC1. PMID: 27056978
  • ARL13B regulates IFT-A-mediated retrograde protein trafficking within cilia through its interaction with INPP5E. PMID: 27927754
  • In neuronal cells, INPP5E knockdown significantly inhibits autophagy by disrupting the autophagosome-lysosome fusion step. PMID: 27340123
  • INPP5E localizes to centrosomes, chromosomes, and kinetochores during early mitosis and translocates to the midzone spindle during mitotic exit. PMID: 28031327
  • INPP5E represents a critical point of convergence between Hedgehog and phosphoinositide signaling at cilia, maintaining transition zone function and Hedgehog-dependent embryonic development. PMID: 27998989
  • PIPKIgamma and INPP5E localize to the centrosome and coordinate the initiation of ciliogenesis. PMID: 26916822
  • These findings establish the first direct link between AURKA and phosphoinositide signaling, suggesting that INPP5E's function in cilia is at least partially mediated through its interactions with AURKA. PMID: 25395580
  • Proteomic analysis identified INPP5E, whose mutations also cause Joubert syndrome, as a novel prenyl-dependent cargo of PDE6D. Mutant PDE6D exhibits reduced binding to INPP5E, leading to impaired INPP5E localization to primary cilia in patient fibroblasts and tissues. PMID: 24166846
  • Twelve different INPP5E mutations have been identified in patients with Joubert syndrome, with an overall mutation frequency of 2.7%. PMID: 23386033
  • These findings indicate that ARL13B, INPP5E, PDE6D, and CEP164 form a distinct functional network involved in JBTS and NPHP, independent of previously defined NPHP and MKS protein networks. PMID: 23150559
  • INPP5E mutations lead to primary cilium signaling defects, ciliary instability, and ciliopathies in humans. PMID: 19668215
  • Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to ciliopathies. PMID: 19668216
  • Functional analysis of the mouse counterpart has been performed. PMID: 10806194
Database Links

HGNC: 21474

OMIM: 213300

KEGG: hsa:56623

STRING: 9606.ENSP00000360777

UniGene: Hs.120998

Involvement In Disease
Joubert syndrome 1 (JBTS1); Mental retardation, truncal obesity, retinal dystrophy, and micropenis (MORMS)
Protein Families
Inositol 1,4,5-trisphosphate 5-phosphatase type IV family
Subcellular Location
Cytoplasm, cytoskeleton, cilium axoneme. Golgi apparatus, Golgi stack membrane; Peripheral membrane protein; Cytoplasmic side. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell projection, ruffle. Cytoplasm. Nucleus.
Tissue Specificity
Detected in brain, heart, pancreas, testis and spleen.

Q&A

What is INPP5E and why is it significant in research?

INPP5E (inositol polyphosphate-5-phosphatase, 72 kDa) is a critical enzyme involved in phosphoinositide metabolism that regulates various cellular processes. Recent studies have identified it as a key player in the phosphoinositide manipulation at immune synapses, controlling TCR signaling cascades . INPP5E has a calculated molecular weight of 644 amino acids and approximately 70 kDa, though it is often observed at 64-66 kDa in experimental conditions . Its importance extends to primary cilia function, with mutations being associated with ciliopathies.

What types of INPP5E antibodies are available for research purposes?

Current research applications utilize several antibody formats targeting INPP5E:

  • Polyclonal antibodies (e.g., rabbit polyclonal IgG) that recognize multiple epitopes

  • Monoclonal antibodies (e.g., mouse IgG1) that provide highly specific single-epitope binding

  • Antibodies targeting different regions of INPP5E, including:

    • Full-length protein (AA 1-644)

    • N-terminal regions (AA 1-133)

    • C-terminal regions

    • Specific internal domains (AA 510-630)

How should I determine the optimal INPP5E antibody for my specific research application?

Selection should be based on:

ApplicationRecommended Antibody TypeKey Considerations
Western BlotBoth polyclonal and monoclonalDilution ratio 1:500-1:2000; observed at 64-66 kDa
ImmunofluorescencePolyclonal preferred for spatial distribution studiesDilution ratio 1:20-1:200; higher background may require optimization
ImmunohistochemistryPolyclonal with appropriate retrievalTE buffer pH 9.0 or citrate buffer pH 6.0 recommended
ImmunoprecipitationHigh-affinity antibodies0.5-4.0 μg per 1.0-3.0 mg total protein lysate
Multiplex assaysConjugation-ready monoclonalPBS-only formulations without BSA/azide for conjugation chemistry

What are the validated tissue and cell models for INPP5E antibody applications?

INPP5E antibodies have been validated in diverse biological samples, with specific positive results in:

TechniqueValidated SamplesNotes
Western BlotSH-SY5Y cells, HEK-293 cells, mouse brain tissue, mouse testis tissue Consistent detection at 64-66 kDa
ImmunoprecipitationHEK-293 cells Effective for protein interaction studies
ImmunohistochemistryHuman testis, kidney, placenta, and spleen tissues Requires optimized antigen retrieval
ImmunofluorescencehTERT-RPE1 cells Particularly useful for ciliary localization studies

How should I design proper controls for INPP5E antibody experiments?

For rigorous experimental design, implement the following controls:

  • Positive controls: Utilize tissues/cells with known INPP5E expression (e.g., HEK-293 cells, mouse brain tissue)

  • Negative controls:

    • Primary antibody omission

    • INPP5E knockdown validation through siRNA as demonstrated in recent studies where Western blot confirmed depletion of the ~70 kDa INPP5E signal

  • Specificity controls: Secondary antibody-only controls to detect non-specific binding, which has been observed in both T cells and APCs in immune synapse studies

What are the recommended storage and handling protocols for INPP5E antibodies?

Different INPP5E antibody formulations require specific storage conditions:

  • Standard formulations: Store at -20°C with PBS containing 0.02% sodium azide and 50% glycerol (pH 7.3). Stable for one year after shipment

  • Conjugation-ready formulations: Store at -80°C in PBS-only buffer (BSA and azide-free) at 1 mg/mL concentration

  • For standard formulations, aliquoting is unnecessary for -20°C storage

  • Some specialized formulations (20μl sizes) contain 0.1% BSA

How can I effectively track INPP5E localization during immune synapse formation?

Recent research has revealed dynamic INPP5E distribution during immune synapse formation:

  • INPP5E signals appear faintly at the immune synapse 2 minutes after T cell-APC conjugation

  • Signal intensity increases 5-10 minutes after conjugation

  • In resting cells, INPP5E localizes to centrioles, but relocates toward the immune synapse upon stimulation

  • For optimal visualization, immunostaining combined with 3D-structured illumination microscopy (3D-SIM) provides detailed spatial resolution

What methodological approaches can validate INPP5E knockdown efficiency?

Effective validation requires multi-parameter assessment:

  • Western blot: Confirm depletion of INPP5E signal at approximately 70 kDa compared to control cells

  • Immunofluorescence: Assess reduction in INPP5E enrichment at centrioles in resting cells

  • Functional assays: Measure decreased INPP5E polarization toward the immune synapse (e.g., reduced from 71.52% in control cells to 38.09% in knockdown cells)

  • Quantification: Express results as percentage of conjugation events showing proper localization

How should I approach colocalization studies involving INPP5E?

For accurate colocalization analysis:

  • Employ triple-staining techniques with INPP5E antibody and known cellular markers

  • Utilize super-resolution microscopy (e.g., 3D-SIM) for precise spatial mapping

  • For centriole/basal body localization, combine with centrosomal markers

  • For immune synapse studies, measure polarization toward the T cell-APC interface

  • Quantify colocalization using appropriate software and statistical metrics (Pearson's correlation, Manders' overlap coefficient)

Why might I observe discrepancies between calculated and observed molecular weights for INPP5E?

While the calculated molecular weight of INPP5E is 70 kDa (644 amino acids), Western blot typically detects it at 64-66 kDa . This discrepancy may result from:

  • Post-translational modifications affecting protein migration

  • Proteolytic processing in specific cell types

  • Secondary/tertiary protein structure influencing SDS-PAGE mobility

  • Alternative splicing generating different isoforms

The consistent observation across multiple studies suggests this is a normal characteristic rather than an experimental artifact.

How can I optimize signal-to-noise ratio when using INPP5E antibodies in immunofluorescence?

Non-specific binding has been reported in both T cells and APCs . To improve signal specificity:

  • Titrate antibody concentration (recommended range: 1:20-1:200)

  • Extend blocking time with 5% BSA or serum matching secondary antibody host

  • Include 0.1-0.3% Triton X-100 for improved penetration

  • Consider antigen retrieval optimization (TE buffer pH 9.0 or citrate buffer pH 6.0)

  • Employ confocal microscopy with appropriate negative controls

  • Use fluorophore-conjugated secondary antibodies with minimal spectral overlap

What are critical considerations when interpreting INPP5E localization in dynamic cellular processes?

When analyzing INPP5E distribution during processes like immune synapse formation:

  • Account for temporal dynamics (signals increase 2-10 minutes after cell conjugation)

  • Consider multiple z-stacks to capture the complete 3D distribution

  • Recognize that antibody accessibility may vary between cellular compartments

  • Compare localization patterns with known INPP5E interaction partners

  • Analyze multiple time points to establish the sequence of recruitment events

  • Quantify signal intensity changes across experimental conditions

How does INPP5E contribute to immune synapse function and TCR signaling?

Recent discoveries highlight INPP5E as a novel regulator of T cell function:

  • INPP5E regulates CD3ζ enrichment at the immune synapse

  • It participates in phosphoinositide manipulation at the synapse, controlling TCR signaling cascades

  • Knockdown experiments demonstrate its critical role in immune synapse formation events

  • The spatial-temporal distribution of INPP5E during immune synapse formation follows a specific pattern, appearing 2 minutes after conjugation and increasing 5-10 minutes after conjugation

What emerging methods are advancing INPP5E functional studies?

Cutting-edge approaches include:

  • Super-resolution microscopy, particularly 3D-structured illumination microscopy (3D-SIM), for detailed visualization of INPP5E localization

  • Matched antibody pairs developed specifically for cytometric bead arrays and multiplex assays

  • Conjugation-ready antibody formats allowing flexible application in ELISAs, multiplex assays, mass cytometry, and multiplex imaging

  • Combined knockdown and live cell imaging approaches to track dynamic INPP5E redistribution

How can researchers integrate INPP5E studies into broader signaling pathway analyses?

For comprehensive signaling studies:

  • Combine INPP5E antibodies with phosphoinositide sensors to correlate enzyme localization with substrate dynamics

  • Utilize matched antibody pairs for multiplexed detection in complex samples

  • Integrate INPP5E research with investigation of interacting partners identified through co-immunoprecipitation studies

  • Apply systems biology approaches to position INPP5E within larger phosphoinositide metabolism networks

  • Correlate INPP5E activity with downstream signaling events such as TCR cascade activation

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.